RHYTHM AI
Rhythm AI's STAR Apollo™ Mapping System is a medical device that utilizes AI and real-time data analysis from existing electrophysiology systems to transform atrial fibrillation (AF) treatment. It identifies repetitive activation patterns and early activation sites in the heart, enabling physicians to create personalized treatment plans. The system is compatible with two commercially available 3D mapping systems and does not require additional consumables.
RHYTHM AI
Rhythm AI's STAR Apollo™ Mapping System is a medical device that utilizes AI and real-time data analysis from existing electrophysiology systems to transform atrial fibrillation (AF) treatment. It identifies repetitive activation patterns and early activation sites in the heart, enabling physicians to create personalized treatment plans. The system is compatible with two commercially available 3D mapping systems and does not require additional consumables.
TL;DR
Headquarters: London, United Kingdom
Founded: 2018
Core product: STAR Mapping System — AI-driven cardiac mapping for atrial fibrillation
Employees (approx.): 12
Known funding: Seed (Sep 2019); total reported ~$2.66M USD
Company Overview
Problem Domain
Atrial fibrillation diagnosis and treatment; cardiac electrophysiology mapping.
Founded
2018
Industry
Medical device / Medtech (cardiac electrophysiology)
Funding Track Record
2660000.00 USD
Investor Signal
“Rinkelberg Capital as lead/backer in Seed”